NewsRoom

Chime Biologics and Waterstone Announce a Strategic Partnership to Empower Antibody-Drug Conjugate (ADC) Development and Manufacturing

/in , , /by

Chime Biologics and Waterstone Announce a Strategic Partnership to Empower Antibody-Drug Conjugate (ADC) Development and Manufacturing Chime Biologics and Waterstone Pharmaceuticals announce a strategic partnership to provide integrated services for the global Antibody-Drug Conjugate (ADC) industry. Chime Biologics will leverage its CMC expertise in biologics to manage Antibody Intermediate, ADC Drug Substance and Drug Product, […]

Read more

Chime Biologics Bridges Innovation and Collaboration at Europe-China Biotech Business Forum 2024

/in , , /by

Chime Biologics Bridges Innovation and Collaboration at Europe-China Biotech Business Forum 2024 November 4, Stockholm, Sweden – Chime Biologics, a leading global CDMO that enables its partners’ success in biologics, bridged Europe-Asia Biotech innovation and collaboration at the Europe-China Biotech Business Forum 2024, a BIO-Europe side event. Bringing together senior pharmaceutical leaders to explore cross-border […]

Read more

Chime Biologics and Korean Listed Company MedPacto Form Strategic Partnership to Accelerate Global Biologics Development and Manufacturing

/in , , /by

Chime Biologics and Korean Listed Company MedPacto Form Strategic Partnership to Accelerate Global Biologics Development and Manufacturing October 28, 2024, Shanghai, China – Chime Biologics, a leading global CDMO that enables its partners’success in biologics, today announced a strategic collaboration with MedPacto, a South Korean clinically staged company listed on KOSDAQ (235980). MedPacto, known for […]

Read more

Chime Biologics congratulates Hope Medicine on HMI-115’s CDE Breakthrough Therapy Designation

/in , /by

Chime Biologics congratulates Hope Medicine on HMI-115’s CDE Breakthrough Therapy Designation Not available.

Read more

Arbele Announces Strategic Collaborations on AI Precision Oncology and Manufacturing to Advance CDH17-Targeted Immunotherapeutics

/in , /by

Arbele Announces Strategic Collaborations on AI Precision Oncology and Manufacturing to Advance CDH17-Targeted Immunotherapeutics SEATTLE, Oct. 9, 2024 /PRNewswire/ — Arbele, a leading innovator in biopharmaceutical & biotechnology focused on targeting cadherin-17 (CDH17), is pleased to announce strategic collaborations in precision oncology using artificial intelligence (AI) to advance targeted immunotherapeutics of bispecific T-cell engagers (TCEs) and antibody-drug conjugates […]

Read more

Chime Biologics Successfully Hosts Fuel BioGrowth Chime Day 2024 Event

/in , /by

Chime Biologics Successfully Hosts Fuel BioGrowth Chime Day 2024 Event September 30, 2024, Wuhan – Chime Biologics, a leading global CDMO that enables its partners’ success in biologics, successfully hosted the “Fuel BioGrowth Chime Day” event on September 27 at the East Lake Hotel in Wuhan. The event gathered top key opinion leaders (KOLs) and […]

Read more

A Brief introduction on the Challenges and Strategies in Antibody Drug Production

/in , /by

A Brief introduction on the Challenges and Strategies in Antibody Drug Production No content available

Read more

Chime Biologics won two awards at the Asia Pacific Biologics CMO Excellence Awards 2024

/in /by

Chime Biologics won two awards at the Asia Pacific Biologics CMO Excellence Awards 2024 Recently, at the 3rd Biologics Contract Manufacturing Asia held in Singapore, Chime Biologics was honored with two prestigious awards at the Asia Pacific Biologics CMO Excellence Awards (APBCEA) 2024 — “Best CDMO Award of the Year” and “Best Biologics CMO Award: […]

Read more

pilot-plant-of-chime-biologics

/in , /by

 pilot-plant-of-chime-biologics No content available

Read more
categoryidArraymk-test